Automated Screen for Fetal Aneuploidy

UnknownOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

March 31, 2019

Study Completion Date

June 30, 2019

Conditions
Trisomy 21 and Other Fetal Aneuploidy
Interventions
DIAGNOSTIC_TEST

blood test

analysis of cell-free DNA in maternal plasma

Trial Locations (6)

Unknown

Royal Prince Alfred Hospital, Sydney

University Hospital Brugmann, Brussels

University of British Columbia, Vancouver

Hospital CUF Descobertas, Lisbon

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia

University College London Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Brugmann University Hospital

OTHER

collaborator

University of British Columbia

OTHER

collaborator

Royal Prince Alfred Hospital, Sydney, Australia

OTHER

collaborator

Hospital Universitario Virgen de la Arrixaca

OTHER

collaborator

Hospital CUF Descobertas, Lisbon, Portugal

UNKNOWN

collaborator

University College London Hospitals

OTHER

lead

BioCeryx

INDUSTRY